Megan S Reinalda
Overview
Explore the profile of Megan S Reinalda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
951
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hay I, Kaggal S, Iniguez-Ariza N, Reinalda M, Wiseman G, Thompson G
Mayo Clin Proc
. 2021 Mar;
96(7):1727-1745.
PMID: 33743997
Objective: To determine whether radioiodine remnant ablation (RRA) reduces cause-specific mortality (CSM) or tumor recurrence (TR) rate after bilateral lobar resection (BLR). Patients And Methods: There were 2952 low-risk adult...
2.
Hickson L, Thorsteinsdottir B, Ramar P, Reinalda M, Crowson C, Williams A, et al.
Nephron
. 2018 Feb;
139(1):1-12.
PMID: 29402792
Background/aims: Over one-third of hospital discharges among dialysis patients are followed by 30-day readmission. The first year after dialysis start is a high-risk time frame. We examined the rate, causes,...
3.
Thorsteinsdottir B, Ramar P, Hickson L, Reinalda M, Albright R, Tilburt J, et al.
BMC Nephrol
. 2017 Oct;
18(1):322.
PMID: 29070040
Background: Efficient and safe delivery of care to dialysis patients is essential. Concerns have been raised regarding the ability of accountable care organizations to adequately serve this high-risk population. Little...
4.
Hay I, Johnson T, Kaggal S, Reinalda M, Iniguez-Ariza N, Grant C, et al.
World J Surg
. 2017 Oct;
42(2):329-342.
PMID: 29030676
Background: Contemporary guidelines for managing PTC advise an approach wherein primary tumor and regional metastases (RM) are completely resected at first surgery and radioiodine remnant ablation (RRA) is restricted to...
5.
Visscher S, Naessens J, Yawn B, Reinalda M, Anderson S, Borah B
BMC Health Serv Res
. 2017 Jun;
17(1):396.
PMID: 28606088
Background: Research addressing value in healthcare requires a measure of cost. While there are many sources and types of cost data, each has strengths and weaknesses. Many researchers appear to...
6.
Hay I, Johnson T, Thompson G, Sebo T, Reinalda M
Surgery
. 2015 Oct;
159(1):11-9.
PMID: 26514317
Background: This study assessed the influence of extrathyroid extension (EE) on cause-specific mortality (CSM) and tumor recurrence (TR) in patients treated for papillary thyroid carcinoma (PTC). Methods: We studied outcome...
7.
Kremers H, Visscher S, Moriarty J, Reinalda M, Kremers W, Naessens J, et al.
Clin Orthop Relat Res
. 2012 Aug;
471(1):206-14.
PMID: 22864619
Background: TKA procedures are increasing rapidly, with substantial cost implications. Determining cost drivers in TKA is essential for care improvement and informing future payment models. Questions/purposes: We determined the components...
8.
Age at diagnosis and the utility of prognostic testing in patients with chronic lymphocytic leukemia
Shanafelt T, Rabe K, Kay N, Zent C, Jelinek D, Reinalda M, et al.
Cancer
. 2010 Jun;
116(20):4777-87.
PMID: 20578179
Background: A study was undertaken to analyze the survival of chronic lymphocytic leukemia (CLL) patients relative to age-matched individuals in the general population and determine the age-stratified utility of prognostic...
9.
Bowen D, Call T, Shanafelt T, Kay N, Schwager S, Reinalda M, et al.
Leuk Lymphoma
. 2010 Mar;
51(4):620-7.
PMID: 20302386
Treatment of autoimmune cytopenia complicating progressive chronic lymphocytic leukemia (CLL) is constrained by intolerance of myelosuppression and the risk of exacerbation of autoimmune cytopenia by purine analogs particularly when used...
10.
Garriock H, Tanowitz M, Kraft J, Dang V, Peters E, Jenkins G, et al.
Am J Psychiatry
. 2010 Mar;
167(5):565-73.
PMID: 20194481
Objective: Because previous preclinical and clinical studies have implicated the endogenous opioid system in major depression and in the neurochemical action of antidepressants, the authors examined how DNA variation in...